I agree that this site is using cookies. You can find further informations here.
X
Tuninetti, V.
37  results:
OpenAccess-fulltext X
Search for persons X
?
1

Lynch syndrome-associated endometrial cancer patient with a..:

Zumstein, L ; Tuninetti, V ; Vaira, M...
info:eu-repo/semantics/altIdentifier/pmid/37434947.  , 2023
Link: https://hdl.handle.net/2..
 
?
2

Ki67 as a Predictor of Response to PARP Inhibitors in Plati..:

Tuninetti, V ; Ghisoni, E ; Pignata, S...
info:eu-repo/semantics/altIdentifier/doi/10.3390/cancers15041032.  , 2023
Link: https://serval.unil.ch/n..
 
?
3

Lynch syndrome-associated endometrial cancer patient with a..:

Zumstein, L ; Tuninetti, V ; Vaira, M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331303/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
4

Immunotherapy for Cervical Cancer: Are We Ready for Prime T..:

Turinetto M ; Valsecchi A. A ; Tuninetti V...
info:eu-repo/semantics/altIdentifier/pmid/35408919.  , 2022
Link: http://hdl.handle.net/23..
 
?
5

Biomarkers of central nervous system involvement from epith..:

Scotto G ; Borella F ; Turinetto M...
info:eu-repo/semantics/altIdentifier/pmid/34943916.  , 2021
Link: http://hdl.handle.net/23..
 
?
6

The Role of PARP Inhibitors in the Ovarian Cancer Microenvi..:

Turinetto M ; Scotto G ; Tuninetti V..
info:eu-repo/semantics/altIdentifier/pmid/34195090.  , 2021
Link: http://hdl.handle.net/23..
 
?
7

Differences in parp inhibitors for the treatment of ovarian..:

Valabrega G ; Scotto G ; Tuninetti V..
info:eu-repo/semantics/altIdentifier/pmid/33921561.  , 2021
Link: http://hdl.handle.net/24..
 
?
8

Ultrafast carbon nanotubes growth on recycled carbon fibers..:

Salas, A ; Medina, C ; Vial, J. T...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925646/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
9

Differences in parp inhibitors for the treatment of ovarian..:

Valabrega G ; Scotto G ; Tuninetti V..
info:eu-repo/semantics/altIdentifier/pmid/33921561.  , 2021
Link: http://hdl.handle.net/23..
 
?
10

Hypersensitivity to platinum salts according to BRCA status..:

Giannone G ; Scotto G ; Katsaros D...
info:eu-repo/semantics/altIdentifier/pmid/33896588.  , 2021
Link: http://hdl.handle.net/23..
 
?
11

Validation of Androgen Receptor loss as a risk factor for t..:

Mittica G ; Goia M ; Gambino A...
info:eu-repo/semantics/altIdentifier/pmid/32366278.  , 2020
Link: http://hdl.handle.net/23..
 
?
12

Immuno-Metabolism and Microenvironment in Cancer: Key Playe..:

Giannone G ; Ghisoni E ; Genta S...
info:eu-repo/semantics/altIdentifier/pmid/32575899.  , 2020
Link: http://hdl.handle.net/23..
 
?
13

Effect of small strain rate variations on the identificatio..:

Tuninetti, V ; Flores, P ; Medina, C..
hal-02279045.  , 2019
Link: https://hal.archives-ouv..
 
?
14

Role of cyclin-dependent kinase inhibitors in endometrial c..:

Giannone G ; Tuninetti V ; Ghisoni E...
info:eu-repo/semantics/altIdentifier/pmid/31083638.  , 2019
Link: http://hdl.handle.net/23..
 
?
15

Role of Mediterranean diet in preventing platinum based gas..:

Ghisoni, E ; Casalone, V ; Giannone, G...
info:eu-repo/semantics/altIdentifier/pmid/31890648.  , 2019
Link: http://hdl.handle.net/23..
 
1-15